Anzeige
Mehr »
Montag, 10.08.2026 - Börsentäglich über 12.000 News
Breaking News: Wirklich beeindruckende Ergebnisse
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
164 Leser
Artikel bewerten:
(1)

Ventilators Market worth $3.10 billion by 2031 - Exclusive Report by MarketsandMarkets

DELRAY BEACH, Fla., Aug. 10, 2026 /PRNewswire/ -- According to MarketsandMarkets, the Ventilators Market is projected to reach USD 3.10 billion by 2031 from USD 2.49 billion in 2026, at a CAGR of 4.4% during the forecast period.

Browse 250 market data Tables and 60 Figures spread through 300 Pages and in-depth TOC on "Ventilators Market- Global Forecast to 2031"

Ventilators Market Size & Forecast:

  • Market Size Available for Years: 2026-2031
  • 2026 Market Size: USD 2.49 billion
  • 2031 Projected Market Size: USD 3.10 billion
  • CAGR (2026-2031): 4.4%

Ventilators Market Trends & Insights:

  • The ventilators market is undergoing a structural transition driven by supplier consolidation and rapid technology evolution. Medtronic's decision to wind down its ventilator product line and Philips' contraction in parts of its hospital and home respiratory portfolio created replacement opportunities, while ZOLL's acquisition of selected Vyaire product lines preserved and consolidated the Bellavista, LTV, Fabian, and 3100 HFOV platforms. Active manufacturers are responding with broader universal platforms, neonatal options, compact transport systems, remote software updates, interoperable data exchange, and automated lung-protective or weaning functions. Hospitals are increasingly evaluating vendors on installed-base support, cybersecurity, service continuity, consumable availability, and integration with patient monitoring and clinical information systems. The result is a shift from stand-alone breathing machines toward connected respiratory-care ecosystems that support ICU, transport, emergency, and step-down workflows.
  • Portable and transportable ventilators are projected to grow at a CAGR of 5.5% and are expected to reach USD 857.1 million by 2031, driven by the expansion of mobile respiratory support in hospitals, ambulance services, air-medical providers, and disaster-response teams.
  • North America holds the largest market share due to its large installed base, high critical-care spending, advanced hospital infrastructure, and strong replacement demand. Asia Pacific is expected to record the fastest growth, supported by hospital construction, ICU and NICU expansion, local manufacturing, government procurement, and broader adoption of cost-competitive ventilators in China, India, and Southeast Asia.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=11018337

Ventilators have been in high demand over the past ten years due to their portability and extensive applications. Their popularity has increased alongside the rise of ambulances and home care services. Advances in miniaturization have made ventilators even more portable, allowing for continuous monitoring of patients' conditions from virtually anywhere. One significant market trend is the development of sensor analog front-end chips (AFEs), which integrate multiple sensor platforms onto a single chip. AFE chips are utilized in ventilators as gas sensors. Additionally, advancements in semiconductors and bioelectronics have enabled the design of energy-efficient circuits, resulting in smaller batteries. There is a growing demand for single-unit ventilators that can cater to all age groups and various applications. These devices are easily adaptable for both home care and critical care settings.

Based on type, the intensive care ventilators segment accounted for the largest share of the ventilators market.

In 2025, the intensive care ventilators segment accounted for the largest share of the ventilators market. ICU ventilators are life-saving to treat critically ill individuals, particularly those with acute respiratory distress, severe pneumonia, ARDS, and post-operative conditions requiring constant respiratory support. The prevalence of respiratory disease, aging population, and rising number of ICU admissions contribute further to the demand.

Technological advances including closed-loop ventilation, lung-protective ventilation, and artificial intelligence-driven monitoring devices increase their effectiveness and performance, rendering them irreplaceable in intensive care units. On the other hand, more hospital-based reimbursement practices for ventilatory support and government funds flowing incessantly into ICU equipment further heighten the market dominance of intensive care ventilators.

Based on age group, the adult & pediatric ventilators segment accounted for the largest share of the ventilators market.

In 2025, the adult/pediatric ventilators segment accounted for the largest share of the ventilators market. Adult & pediatric ventilators were the leading segment of the ventilators market because of the high incidence of respiratory disorders among these age groups. Diseases like Chronic Obstructive Pulmonary Disease (COPD), Acute Respiratory Distress Syndrome (ARDS), asthma, and pneumonia occur more frequently in adults, especially the elderly, and hence have created a large demand for ventilators in home care and hospitals. Also, premature deliveries and neonatal respiratory distress syndrome (NRDS) fuel the demand for pediatric ventilators, particularly in neonatal intensive care units (NICUs). The aging global population also enhances the demand for adult ventilators since elderly people are more susceptible to serious respiratory illnesses.

Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=11018337

Based on end user, the hospitals & clinics segment accounted for the largest share of the ventilators market.

The hospitals & clinics segment held the maximum market share for ventilators owing to the strong patient flow in need of critical care and respiratory therapy. Hospitals and clinics serve as the primary medical centers for treating severe respiratory diseases such as COPD, ARDS, pneumonia, and post-surgical complications. These conditions often require the use of both invasive and non-invasive ventilators, particularly in intensive care units (ICUs), emergency departments, and surgical wards.

Moreover, hospitals treat complicated and risky cases that need constant monitoring and life-sustaining devices, and therefore advanced ICU ventilators are needed to manage these patients. Government investments in healthcare facilities, expanding ICU bed availability, and higher admissions as a result of aging populations also fuel demand for ventilators in hospitals.

The Asia Pacific market is expected to grow at a higher CAGR during the forecast period.

The Asia Pacific ventilator market is projected to experience significant growth at a higher compound annual growth rate (CAGR) due to several key factors. The rising incidence of respiratory conditions such as COPD, asthma, and pneumonia, along with increasing air pollution levels, is driving the demand for ventilators, particularly in countries like China, India, and Japan. Additionally, the expansion of healthcare infrastructure, government investments in ICU beds, and an aging population in nations such as Japan and China are further propelling market growth. The increasing use of homecare ventilators, driven by rising hospital costs and the availability of affordable, locally produced ventilators in India and China, is also contributing to this rapid expansion. Together, these factors position the Asia Pacific region as the fastest-growing ventilator market compared to other regions in the coming years.

Key Players

Leading players in the Ventilators companies include Bio-Medical Electronics Co., Ltd. (China), ResMed (US), Nihon Kohden Corporation (Japan), ZOLL Medical Corporation (US), Getinge AB (Sweden), Drägerwerk AG & Co. KGaA (Germany), ICU Medical, Inc. (US), Hamilton Medical (Switzerland), Löwenstein Medical SE & Co. KG (Germany), Fisher & Paykel Healthcare Limited (New Zealand), Skanray Technologies Ltd. (India), aXcent Medical GmbH (Germany), Metran Co., Ltd. (Japan), MAGNAMED (Brazil), Leistung Ingeniería SRL (Argentina), Breas Medical AB (Sweden), Airon Corporation (US), TRITON Electronic Systems Ltd. (Russia), Bio-Med Devices, Inc. (US), HEYER Medical AG (Germany), AgVa Healthcare (India), Biodesign Innovation Labs (India), NOCCARC Robotics Pvt. Ltd. (India), Umbulizer (India), Schiller Healthcare India Pvt. Ltd. (India), and AVI Healthcare (India).

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=11018337

Browse Adjacent Market: Medical Devices Market Research Reports &Consulting

See More Latest Medical Devices Reports:

Patient Monitoring Devices Market by Product (Multiparameter, Glucose CGM, Wearables, EEG, EMG, ECG, ILR, MCT, Pulse Oximeter, Fetal, Neonatal, BP, Hemodynamic, Spirometer, Capnograph), End User (Hospital, ICU, ASC), & Region - Global Forecast to 2031

Respiratory Care Devices Market by Product (Brightfield Scanner, Enterprise Software, Storage System), Application (Teleconsultation, Disease Diagnosis, Drug Discovery), Indication (Onco, Hemo), End User (Pharma & Biotech, Hospital) Al- Global Forecast to 2031

About MarketsandMarkets

MarketsandMarkets has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore, which integrates research and provides ecosystem-wide visibility into revenue shifts.

MarketsandMarkets SalesPlay is an AI-driven Revenue Intelligence Co-Pilot designed to help revenue teams prioritize the right accounts, identify critical changes early, and surface opportunities ahead of demand, so pipeline builds naturally and deals close with greater consistency.

To find out more, visit www.MarketsandMarkets.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/ventilators-market.asp
Content Source: https://www.marketsandmarkets.com/PressReleases/ventilators.asp

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/ventilators-market-worth-3-10-billion-by-2031---exclusive-report-by-marketsandmarkets-302846932.html

© 2026 PR Newswire
Achtung, Korrektur!
Die Börsen laufen heiß. Trotz geopolitischer Krisen und steigender Zinsen klettern viele Indizes weiter Richtung Allzeithoch. Doch unter der Oberfläche zeigen sich erste Risse: Der Abverkauf bei Halbleiter-, KI- und Space-Aktien macht deutlich, wie schnell sich die Stimmung drehen kann.

Besonders gefährlich ist die aktuelle Gemengelage aus schwacher Saisonalität, dünner Liquidität in den Sommermonaten und historisch hohen Bewertungen. Selbst vermeintlich sichere Blue Chips sind inzwischen teuer bewertet und damit anfällig für Korrekturen. Gleichzeitig liefern technische Indikatoren erste Warnsignale. So werden viele Rekordstände nicht mehr bestätigt.

Für Anleger steigen die Risiken spürbar. Wer jetzt nicht genauer hinschaut, läuft Gefahr, auf dem falschen Fuß erwischt zu werden.

In unserem aktuellen Spezialreport zeigen wir fünf Aktien, bei denen die Abwärtsrisiken besonders hoch sind – und wo sich Gewinnmitnahmen oder sogar Short-Strategien anbieten könnten.

Jetzt den kostenlosen Report sichern – bevor die Korrektur Fahrt aufnimmt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.